A kind of preparation method of 5-methoxytryptamine

5-methoxytryptamine is directly produced through simplified condensation and amino reaction of 4-halobutyraldehyde dimethanol, which solves the problems of complex processes and harmful raw materials in the prior art. , realizes efficient preparation of 5-methoxytryptamine suitable for industrial production.

CN114230507BActive Publication Date: 2024-11-12FUYANG XINYIHUA PHARM TECH CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202111673014.6
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2021-12-31
Publication Date
2024-11-12
Estimated Expiration
2041-12-31

AI Technical Summary

Technical Problem

The existing preparation methods for 5-methoxytryptamine are cumbersome, the raw materials used are numerous and harmful, and are not suitable for large-scale industrial production.

Method used

Condensation with 4-methoxyphenylhydrazine salt and 4-halobutyraldehyde dimethanol in the presence of an acid to obtain 3-(2-haloethyl)-5-methoxy-1H-indole, and then The ammonia water reaction directly obtains 5-methoxytryptamine, simplifying the process flow and improving the yield.

Benefits of technology

The preparation of 5-methoxytryptamine with few steps and high yields is achieved. The intermediate does not require purification, and is suitable for large-scale industrial production, and has a purity of more than 99.0%.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0003453570700000021
    Figure BDA0003453570700000021
  • Figure BDA0003453570700000071
    Figure BDA0003453570700000071
  • Figure BDA0003453570700000081
    Figure BDA0003453570700000081
Patent Text Reader

Abstract

The present invention provides a preparation method of 5-methoxytryptamine. The preparation method of the 5-methoxytryptamine comprises the following steps: (1) reacting 4-methoxyphenylhydrazine salt and 4-halobutyraldehyde dimethyl acetal in the presence of an acid to obtain 3-(2-haloethyl)-5-methoxy-1H-indole; (2) reacting 3-(2-haloethyl)-5-methoxy-1H-indole obtained in step (1) with ammonia water to obtain 5-methoxytryptamine. The present invention adopts a total synthesis method using 4-methoxyphenylhydrazine hydrochloride and 4-chlorobutyraldehyde dimethyl acetal as starting materials, and obtains a final product through steps such as cyclization and amination. The entire process flow of the method of the present invention is simple to operate, and the intermediate obtained in the intermediate step does not need to be refined or dried to directly enter the next step of reaction, which is suitable for large-scale industrial production.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of chemical pharmaceuticals, and specifically relates to a method for preparing 5-methoxytryptamine. Background Art

[0002] 5-Methoxytryptamine is a tryptamine derivative that is closely related to the neurotransmitters melatonin and serotonin. It acts as a full agonist on 5-HT1, 5-HT2, 5-HT4, 5-HT6, and 5-HT7 receptors, but has no affinity for 5-HT3 receptors. It is a melatonin-related compound.

[0003] At present, with the progress of society and the development of science and technology, the use value and application of 5-methoxytryptamine have received extensive attention, but there are different processes for the preparation of 5-methoxytryptamine.

[0004] CN110818610A discloses a method for preparing melatonin. The method for preparing melatonin comprises the following steps: (a) phthalimide, 1,3-dichloropropane, sodium iodide and ethyl acetoacetate are reacted in a solvent under the action of a base to obtain compound I; (b) compound I and p-methoxyphenyl diazonium salt are subjected to a ring-closing reaction in the presence of a base and a solvent to obtain compound II; (c) compound II is hydrolyzed under alkaline conditions and then decarboxylated under acidic conditions to obtain compound III; (d) compound III is subjected to an acetylation reaction to obtain melatonin. The patent process has complicated steps, many types of raw materials, and uses 1,3-dichloropropane, which is harmful to the human body.

[0005] CN110229092A discloses a method for efficiently producing melatonin, comprising the following steps: S1: 5-methoxyindole (1) is used as a raw material, and a phosgene reaction solvent is added to oxalylate 5-methoxyindole, thereby reacting to generate a compound (2); S12: the prepared compound (2) is allowed to stand, and then an ammonium hydroxide solvent is mixed with it according to a certain dosage to generate a compound (3); S3: after the compound (3) is generated, a lithium aluminum hydride reagent is added to cause a reduction reaction to generate a compound (4); S4: a certain amount of acetic anhydride reagent is added to the generated compound (5) as the final reaction solvent to react to generate a compound (6), namely melatonin. The synthesis of 5-methoxytryptamine involves complex procedures, harsh reaction conditions, and the raw materials and reagents used are highly harmful to the environment. In addition, highly toxic substances such as phosgene and phosgene and flammable and explosive substances such as lithium aluminum hydride are used, which is not conducive to industrial production operations.

[0006] Therefore, it is urgent to develop a preparation method of 5-methoxytryptamine with fewer steps, high yield and suitable for large-scale industrial production. Summary of the invention

[0007] In view of the shortcomings of the prior art, the present invention aims to provide a method for preparing 5-methoxytryptamine. The method has fewer steps and a high yield, and the intermediate obtained in the intermediate step can directly enter the next step of reaction without purification and drying, and is suitable for large-scale industrial production.

[0008] To achieve this object, the present invention adopts the following technical solutions:

[0009] In a first aspect, the present invention provides a method for preparing 5-methoxytryptamine, the method for preparing 5-methoxytryptamine comprising the following steps:

[0010] (1) in the presence of an acid, reacting 4-methoxyphenylhydrazine salt with 4-halobutyraldehyde dimethyl acetal to obtain 3-(2-haloethyl)-5-methoxy-1H-indole;

[0011] (2) reacting the 3-(2-haloethyl)-5-methoxy-1H-indole obtained in step (1) with aqueous ammonia to obtain 5-methoxytryptamine.

[0012] The synthetic route is as follows:

[0013]

[0014] Wherein, HY1 represents any pharmaceutically acceptable salt of 4-methoxyphenylhydrazine; HY2 represents any acid, Y1 and Y2 may be the same or different; and X represents a halogen.

[0015] Preferably, the mass ratio of the 4-methoxyphenylhydrazine salt, 4-halobutyraldehyde dimethyl acetal and the acid is (0.5-2):(0.5-2):(0.05-0.5);

[0016] The first "0.5-2" can be, for example, 0.5, 1, 1.5, 2, etc.;

[0017] The second "0.5-2" can be, for example, 0.5, 1, 1.5, 2, etc.;

[0018] Here, “0.05-0.5” can be, for example, 0.05, 0.1, 0.2, 0.3, 0.4, 0.5, etc.

[0019] Preferably, in step (1), the 4-methoxyphenylhydrazine salt is selected from any one or a combination of at least two of 4-methoxyphenylhydrazine hydrochloride, 4-methoxyphenylhydrazine sulfate, 4-methoxyphenylhydrazine acetate, 4-methoxyphenylhydrazine maleate, 4-methoxyphenylhydrazine citrate or 4-methoxyphenylhydrazine oxalate, preferably 4-methoxyphenylhydrazine hydrochloride.

[0020] Preferably, in step (1), the 4-halobutyraldehyde dimethyl acetal is selected from any one of 4-chlorobutyraldehyde dimethyl acetal, 4-fluorobutyraldehyde dimethyl acetal, 4-bromobutyraldehyde dimethyl acetal and 4-fluorobutyraldehyde dimethyl acetal, or a combination of at least two thereof, preferably 4-chlorobutyraldehyde dimethyl acetal.

[0021] Preferably, in step (1), the acid is selected from any one of hydrochloric acid, sulfuric acid, acetic acid, maleic acid, citric acid or oxalic acid, or a combination of at least two thereof, preferably hydrochloric acid.

[0022] Preferably, in step (1), the mass percentage of the acid is 20-50%, for example, it can be 20%, 25%, 30%, 35%, 40%, 40%, 50%, etc., preferably 30-36%.

[0023] Preferably, in step (1), the reaction is carried out in a solvent.

[0024] Preferably, the solvent is an alcohol solvent.

[0025] Preferably, the alcohol solvent is selected from any one of methanol, ethanol, isopropanol, n-propanol, isobutanol, tert-butanol or n-butanol, or a combination of at least two thereof.

[0026] Preferably, the mass ratio of the 4-methoxyphenylhydrazine salt, 4-halobutyraldehyde dimethyl acetal, acid and solvent is (0.5-2):(0.5-2):(0.05-0.5):(1-10);

[0027] The first "0.5-2" can be, for example, 0.5, 1, 1.5, 2, etc.;

[0028] The second "0.5-2" can be, for example, 0.5, 1, 1.5, 2, etc.;

[0029] Here, “0.05-0.5” can be, for example, 0.05, 0.1, 0.2, 0.3, 0.4, 0.5, etc.;

[0030] Here, “1-10” can be, for example, 1, 2, 4, 6, 8, 10, etc.

[0031] Preferably, in step (1), the reaction temperature is 70-80°C, for example, 70°C, 72°C, 74°C, 76°C, 78°C, 80°C, etc., and the reaction time is 8-16h, for example, 8h, 9h, 10h, 11h, 12h, 13h, 14h, 15h, 16h, etc.

[0032] Preferably, in step (1), the post-treatment after the reaction is: cooling the reaction solution and then concentrating it.

[0033] Preferably, in step (2), the mass ratio of the 3-(2-haloethyl)-5-methoxy-1H-indole to aqueous ammonia is 1:(0.5-5), for example, it can be 1:0.5, 1:1, 1:2, 1:2.5, 1:3, 1:3.5, 1:4, 1:4.5, 1:5, etc.

[0034] Preferably, in step (1), the mass percentage of the ammonia water is 10-40%, for example, it can be 10%, 15%, 20%, 25%, 30%, 35%, 40%, etc., preferably 25-28%.

[0035] Preferably, in step (2), the reaction is carried out in a solvent.

[0036] Preferably, the solvent is an alcohol solvent.

[0037] Preferably, the alcohol solvent is selected from any one of methanol, ethanol, isopropanol, n-propanol, isobutanol, tert-butanol or n-butanol, or a combination of at least two thereof.

[0038] Preferably, the mass ratio of the 3-(2-haloethyl)-5-methoxy-1H-indole, aqueous ammonia and solvent is 1:(0.5-5):(1-10);

[0039] Here, “0.5-5” can be, for example, 0.5, 1, 2, 3, 4, 5, etc.;

[0040] Here, “1-10” can be, for example, 1, 2, 4, 6, 8, 10, etc.

[0041] Preferably, in step (2), the reaction temperature is 80-90°C, for example, it can be 80°C, 82°C, 84°C, 86°C, 88°C, 90°C, etc., and the reaction time is 8-16h, for example, it can be 8h, 9h, 10h, 11h, 12h, 13h, 14h, 15h, 16h, etc.

[0042] Preferably, in step (2), the post-treatment after the reaction is: cooling, concentrating, diluting and filtering the reaction solution in sequence to obtain the crude product of 5-methoxytryptamine.

[0043] Preferably, the solvent used for the dilution is water.

[0044] Preferably, the amount of water added is 2-10 times that of the concentrated product, for example, it can be 2 times, 3 times, 4 times, 5 times, 6 times, 7 times, 8 times, 9 times, 10 times, etc.

[0045] Preferably, the dilution is carried out during stirring, the stirring temperature is 20-30°C, for example, 20°C, 22°C, 24°C, 26°C, 28°C, 30°C, etc., and the stirring time is 20-40min, for example, 20min, 25min, 30min, 35min, 40min, etc.

[0046] Preferably, step (3) is further performed after step (2): dissolving the crude 5-methoxytryptamine in an aqueous solution of ethanol, and then decolorizing, crystallizing, centrifuging and drying in sequence to obtain a pure 5-methoxytryptamine.

[0047] Preferably, the mass percentage of the ethanol aqueous solution is 10-60%, for example, it can be 10%, 20%, 30%, 40%, 50%, 60%, etc.

[0048] Preferably, in step (3), the mass ratio of the crude 5-methoxytryptamine to the aqueous solution of ethanol is 1:(1-5), for example, it can be 1:1, 1:2, 1:2.5, 1:3, 1:3.5, 1:4, 1:4.5, 1:5, etc.

[0049] Preferably, in step (3), the dissolution temperature is 50-90°C, for example, it can be 50°C, 55°C, 60°C, 65°C, 70°C, 75°C, 80°C, 85°C, 90°C, etc., preferably 75-85°C.

[0050] Preferably, in step (3), the decolorization adopts activated carbon, and the mass ratio of the crude 5-methoxytryptamine to the activated carbon is 1:(0.01-0.1), for example, it can be 1:0.01, 1:0.02, 1:0.04, 1:0.06, 1:0.08, 1:0.1, etc.

[0051] Preferably, in step (3), the bleaching temperature is 75-85°C, for example, it can be 75°C, 76°C, 78°C, 80°C, 82°C, 84°C, 85°C, etc., and the bleaching time is 20-40min, for example, it can be 20min, 25min, 30min, 35min, 40min, etc.

[0052] Preferably, in step (3), the crystallization temperature is below 10°C, for example, it can be 10°C, 8°C, 6°C, 4°C, 2°C, 0°C, etc., and the crystallization time is 0.5-2h, for example, it can be 0.5h, 0.6h, 0.8h, 1h, 1.2h, 1.4h, 1.6h, 1.8h, 2h, etc.

[0053] Preferably, in step (3), the centrifugal rotation speed is 3000-8000 rpm, for example, it can be 3000 rpm, 4000 rpm, 5000 rpm, 6000 rpm, 7000 rpm, 8000 rpm, etc.

[0054] As a preferred technical solution of the present invention, the preparation method of 5-methoxytryptamine comprises the following steps:

[0055] (1) adding 4-chlorobutyraldehyde dimethyl acetal to a mixed solution of 4-methoxyphenylhydrazine hydrochloride, ethanol and hydrochloric acid, stirring and reacting at 70-80° C. for 8-16 hours, cooling and concentrating after the reaction to obtain 3-(2-haloethyl)-5-methoxy-1H-indole;

[0056] (2) adding 3-(2-haloethyl)-5-methoxy-1H-indole to a mixture of ammonia water and ethanol, stirring and reacting at 80-90° C. for 8-16 hours, and after the reaction is completed, cooling, concentrating, diluting and filtering are performed in sequence to obtain a crude product of 5-methoxytryptamine;

[0057] (3) The crude product of 5-methoxytryptamine is added to an aqueous solution of ethanol, and then decolorized with activated carbon, crystallized, centrifuged and dried to obtain a pure product of 5-methoxytryptamine.

[0058] Compared with the prior art, the present invention has the following beneficial effects:

[0059] (1) The present invention adopts a total synthesis method using 4-methoxyphenylhydrazine hydrochloride and 4-chlorobutyraldehyde dimethyl acetal as starting materials, and obtains the final product through steps such as cyclization and amination. The entire process flow of the method of the present invention is simple to operate, and the intermediate obtained in the intermediate step does not need to be refined or dried and can directly enter the next step of reaction, which is suitable for large-scale industrial production;

[0060] (2) The two-step total yield of the preparation method of 5-methoxytryptamine of the present invention is above 75%; the purity of the purified 5-methoxytryptamine is above 99.0%. DETAILED DESCRIPTION

[0061] The technical solution of the present invention is further described below by specific implementation methods. It should be understood by those skilled in the art that the embodiments are only to help understand the present invention and should not be regarded as specific limitations of the present invention.

[0062] Example 1

[0063] This embodiment provides a method for preparing 5-methoxytryptamine, and the method for preparing 5-methoxytryptamine comprises the following steps:

[0064] The synthetic route is:

[0065]

[0066] (1) 4-methoxyphenylhydrazine hydrochloride (250 g, 1.43 mol), ethanol (750 g), and 30% hydrochloric acid (75 g, 0.62 mol) were added to a 2 L four-necked round-bottomed reaction flask equipped with a mechanical stirrer, a thermometer, and a reflux condenser. 4-chlorobutyraldehyde dimethyl acetal (250 g, 1.64 mol) was added at once under stirring. The temperature was raised to 75° C. and reacted for 12 h. When TLC showed that the reaction was complete, heating was stopped, the temperature was lowered to 55° C., and the concentrated solution was concentrated under reduced pressure to obtain 600 g of a concentrated solution. The purity of 3-(2-haloethyl)-5-methoxy-1H-indole in the concentrated solution was 98.2%;

[0067] (2) In a 5L autoclave equipped with stirring and a thermometer, add the concentrated solution (300g) obtained in step (1), ethanol (900g), and 27% ammonia water (480g), check that the seal is good, stir evenly, heat to 85°C, react for 12h, stop heating, cool, evaporate ethanol under reduced pressure, add water (900g), cool to 25°C, stir for 30min, and filter to obtain 310g of crude product. The purity of the crude product is 98.7%;

[0068] (3) Add the crude 5-methoxytryptamine (310 g) of step (2), ethanol (155 g), and water (775 g) to a 2 L four-necked round-bottomed reaction flask with mechanical stirring, a thermometer, and a reflux condenser, stir evenly, heat to 80° C., add activated carbon (5 g), stir for 30 min, filter while hot into a crystallization reaction flask with mechanical stirring, cool to 5° C. with ice brine, stir for 30 min, filter, and dry to obtain 210 g of the target compound as a white solid (yield: 77.1%, purity: 99.45%), melting point: 119-121° C.;

[0069] 1 HNMR(CDCl3): δ10.58(bs,1H),7.20(t,J=8.78Hz;1H),7.07(s,1H),6.98 (s,1H),6.71-6.68(m,1H),3.75(s,3H),2.81-2.69(m,4H),1.39(bs,2H).

[0070] Example 2

[0071] This embodiment provides a method for preparing 5-methoxytryptamine, and the method for preparing 5-methoxytryptamine comprises the following steps:

[0072] The synthetic route is:

[0073]

[0074] (1) 4-methoxyphenylhydrazine hydrochloride (500 g, 2.86 mol), ethanol (1500 g), and 32% hydrochloric acid (150 g, 1.24 mol) were added to a 5 L four-necked round-bottomed reaction flask equipped with a mechanical stirrer, a thermometer, and a reflux condenser. 4-chlorobutyraldehyde dimethyl acetal (500 g, 3.25 mol) was added at once under stirring. The temperature was raised to 70° C. and reacted for 13 h. When TLC showed that the reaction was complete, heating was stopped, the temperature was lowered to 50° C., and the concentrated solution was concentrated under reduced pressure to obtain 1252 g of a concentrated solution. The purity of 3-(2-haloethyl)-5-methoxy-1H-indole in the concentrated solution was 98.5%;

[0075] (2) In a 5L autoclave equipped with stirring and a thermometer, add the concentrated solution (600g) obtained in step (1), ethanol (1800g), and 25% ammonia water (960g), check that the seal is good, stir evenly, heat to 80°C, react for 13h, stop heating, cool, evaporate ethanol under reduced pressure, add water (1800g), cool to 30°C, stir for 30min, and filter to obtain 620g of crude product. The purity of the crude product is 99.1%;

[0076] (3) Add the crude 5-methoxytryptamine (620 g), ethanol (310 g), and water (1550 g) of step (2) to a 2L four-necked round-bottomed reaction flask with mechanical stirring, a thermometer, and a reflux condenser, stir evenly, heat to 75°C, add activated carbon (6.2 g), stir for 25 min, filter while hot into a crystallization reaction flask with mechanical stirring, cool to 0°C with ice brine, stir for 25 min, filter, and dry to obtain 420 g of the target compound as a white solid (yield: 77.1%, purity: 99.56%), melting point: 119-121°C;

[0077] 1 HNMR(CDCl3): δ10.58(bs,1H),7.20(t,J=8.78Hz;1H),7.07(s,1H),6.98 (s,1H),6.71-6.68(m,1H),3.75(s,3H),2.81-2.69(m,4H),1.39(bs,2H).

[0078] Example 3

[0079] This embodiment provides a method for preparing 5-methoxytryptamine, and the method for preparing 5-methoxytryptamine comprises the following steps:

[0080] The synthetic route is:

[0081]

[0082] (1) 4-methoxyphenylhydrazine hydrochloride (100 g, 0.57 mol), ethanol (300 g), and 36% hydrochloric acid (30 g, 0.25 mol) were added to a 2 L four-necked round-bottomed reaction flask equipped with a mechanical stirrer, a thermometer, and a reflux condenser. 4-chlorobutyraldehyde dimethyl acetal (100 g, 0.66 mol) was added at once under stirring. The temperature was raised to 85° C. and reacted for 10 h. When TLC showed that the reaction was complete, heating was stopped, the temperature was lowered to 60° C., and the concentrated solution was concentrated under reduced pressure to obtain 235 g of a concentrated solution. The purity of 3-(2-haloethyl)-5-methoxy-1H-indole in the concentrated solution was 99.0%;

[0083] (2) In a 5L autoclave equipped with stirring and a thermometer, add the concentrated solution (120g) obtained in step (1), ethanol (360g), and 28% ammonia water (190g), check that the seal is good, stir evenly, heat to 90°C, react for 10h, stop heating, cool, evaporate ethanol under reduced pressure, add water (360g), cool to 20°C, stir for 30min, and filter to obtain 125g of a crude product. The purity of the obtained crude product is 98.64%;

[0084] (3) Add the crude 5-methoxytryptamine (125 g), ethanol (60 g), and water (310 g) of step (2) to a 2L four-necked round-bottomed reaction flask equipped with mechanical stirring, a thermometer, and a reflux condenser, stir evenly, heat to 90° C., add activated carbon (1.25 g), stir for 20 min, filter while hot into a crystallization reaction flask equipped with mechanical stirring, cool to 10° C. with ice brine, stir for 20 min, filter, and dry to obtain 85 g of the target compound as a white solid (yield: 78.4%, purity: 99.53%), melting point: 119-121° C.;

[0085] 1 HNMR(CDCl3): δ10.58(bs,1H),7.20(t,J=8.78Hz;1H),7.07(s,1H),6.98 (s,1H),6.71-6.68(m,1H),3.75(s,3H),2.81-2.69(m,4H),1.39(bs,2H).

[0086] Example 4

[0087] This embodiment provides a method for preparing 5-methoxytryptamine, which is different from Embodiment 1 only in that the 4-methoxyphenylhydrazine hydrochloride in step (1) is replaced by an equal mass of 4-methoxyphenylhydrazine sulfate, and the other raw materials and preparation steps are the same as those in Embodiment 1.

[0088] Example 5

[0089] This embodiment provides a method for preparing 5-methoxytryptamine, which is different from Embodiment 1 only in that the hydrochloric acid in step (1) is replaced by sulfuric acid of equal mass, and the other raw materials and preparation steps are the same as those in Embodiment 1.

[0090] Example 6

[0091] This embodiment provides a method for preparing 5-methoxytryptamine, which is different from Embodiment 1 only in that the ethanol in step (1) is replaced by isopropanol of equal mass, and the other raw materials and preparation steps are the same as those in Embodiment 1.

[0092] Example 7

[0093] This embodiment provides a method for preparing 5-methoxytryptamine, which is different from Embodiment 1 only in that the 4-chlorobutyraldehyde dimethyl acetal in step (1) is replaced by an equal mass of 4-bromobutyraldehyde dimethyl acetal, and the other raw materials and preparation steps are the same as those in Embodiment 1.

[0094] Example 8

[0095] This embodiment provides a method for preparing 5-methoxytryptamine, which is different from Embodiment 1 only in that the ethanol in step (2) is replaced by an equal mass of methanol, and the other raw materials and preparation steps are the same as those in Embodiment 1.

[0096] Test Case

[0097] Test sample: 5-methoxytryptamine obtained in Example 1-8;

[0098] Test method: HPLC was used to test the purity of 5-methoxytryptamine in the test sample; the total yield (%) of the route was calculated according to the feed amount of the starting material 4-methoxyphenylhydrazine hydrochloride in step (1). The test results are shown in Table 1:

[0099] Table 1

[0100]

[0101]

[0102] From the test results in Table 1, it can be seen that the two-step total yield of the preparation method of 5-methoxytryptamine of the present invention is more than 75.0%; the purity of the purified 5-methoxytryptamine is more than 99.0%. It is explained that the present invention adopts a total synthesis method using 4-methoxyphenylhydrazine hydrochloride and 4-chlorobutyraldehyde dimethyl acetal as starting materials, and obtains the final product through steps such as cyclization and amination. The entire process of the method of the present invention is simple to operate, and the intermediate obtained in the intermediate step does not need to be refined or dried and can directly enter the next step of reaction, which is suitable for large-scale industrial production.

[0103] The applicant declares that the present invention illustrates the preparation method of 5-methoxytryptamine through the above-mentioned embodiments, but the present invention is not limited to the above-mentioned embodiments, that is, it does not mean that the present invention must rely on the above-mentioned embodiments to be implemented. Those skilled in the art should understand that any improvement of the present invention, equivalent replacement of various raw materials of the product of the present invention, addition of auxiliary components, selection of specific methods, etc., all fall within the protection scope and disclosure scope of the present invention.

Claims

1. A method for preparing 5-methoxytryptamine, characterized in that: The preparation method of the 5-methoxytryptamine comprises the following steps: (1) in the presence of an acid, reacting 4-methoxyphenylhydrazine salt with 4-halobutyraldehyde dimethyl acetal to obtain 3-(2-haloethyl)-5-methoxy-1H-indole; (2) reacting the 3-(2-haloethyl)-5-methoxy-1H-indole obtained in step (1) with aqueous ammonia to obtain 5-methoxytryptamine; The acid is selected from any one of hydrochloric acid, sulfuric acid, acetic acid, maleic acid, citric acid or oxalic acid, or a combination of at least two thereof; The mass percentage of the acid is 20-50%; In step (1), the reaction is carried out in a solvent; The solvent is an alcohol solvent; The alcohol solvent is selected from any one or a combination of at least two of methanol, ethanol, isopropanol, n-propanol, isobutanol, tert-butanol or n-butanol; In step (1), the post-reaction post-treatment is: cooling the reaction solution and then concentrating it; The mass ratio of the 4-methoxyphenylhydrazine salt, 4-halobutyraldehyde dimethyl acetal, acid and solvent is (0.5-2):(0.5-2):(0.05-0.5):(1-10).

2. The method for preparing 5-methoxytryptamine according to claim 1, characterized in that: In step (1), the 4-methoxyphenylhydrazine salt is selected from any one of 4-methoxyphenylhydrazine hydrochloride, 4-methoxyphenylhydrazine sulfate, 4-methoxyphenylhydrazine acetate, 4-methoxyphenylhydrazine maleate, 4-methoxyphenylhydrazine citrate or 4-methoxyphenylhydrazine oxalate, or a combination of at least two thereof.

3. The method for preparing 5-methoxytryptamine according to claim 2, characterized in that: In step (1), the 4-methoxyphenylhydrazine salt is 4-methoxyphenylhydrazine hydrochloride.

4. The method for preparing 5-methoxytryptamine according to claim 1, characterized in that: In step (1), the 4-halobutyraldehyde dimethyl acetal is selected from any one of 4-chlorobutyraldehyde dimethyl acetal, 4-fluorobutyraldehyde dimethyl acetal, 4-bromobutyraldehyde dimethyl acetal and 4-fluorobutyraldehyde dimethyl acetal, or a combination of at least two thereof.

5. The method for preparing 5-methoxytryptamine according to claim 4, characterized in that: In step (1), the 4-halobutyraldehyde dimethyl acetal is 4-chlorobutyraldehyde dimethyl acetal.

6. The method for preparing 5-methoxytryptamine according to claim 1, characterized in that: In step (1), the acid is hydrochloric acid.

7. The method for preparing 5-methoxytryptamine according to claim 1, characterized in that: In step (1), the mass percentage of the acid is 30-36%.

8. The method for preparing 5-methoxytryptamine according to claim 1, characterized in that: In step (1), the reaction temperature is 70-80°C, and the reaction time is 8-16h.

9. The method for preparing 5-methoxytryptamine according to claim 1, characterized in that: In step (2), the mass ratio of the 3-(2-haloethyl)-5-methoxy-1H-indole to aqueous ammonia is 1:(0.5-5).

10. The method for preparing 5-methoxytryptamine according to claim 1, characterized in that: In step (2), the mass percentage of the ammonia water is 10-40%.

11. The method for preparing 5-methoxytryptamine according to claim 10, characterized in that: In step (2), the mass percentage of the ammonia water is 25-28%.

12. The method for preparing 5-methoxytryptamine according to claim 1, characterized in that: In step (2), the reaction is carried out in a solvent.

13. The method for preparing 5-methoxytryptamine according to claim 12, characterized in that: The solvent is an alcohol solvent.

14. The method for preparing 5-methoxytryptamine according to claim 13, characterized in that: The alcohol solvent is selected from any one of methanol, ethanol, isopropanol, n-propanol, isobutanol, tert-butanol or n-butanol, or a combination of at least two thereof.

15. The method for preparing 5-methoxytryptamine according to claim 12, characterized in that: The mass ratio of the 3-(2-haloethyl)-5-methoxy-1H-indole, aqueous ammonia and solvent is 1:(0.5-5):(1-10).

16. The method for preparing 5-methoxytryptamine according to claim 1, characterized in that: In step (2), the reaction temperature is 80-90°C, and the reaction time is 8-16h.

17. The method for preparing 5-methoxytryptamine according to claim 1, characterized in that: In step (2), the post-treatment after the reaction is: cooling, concentrating, diluting and filtering the reaction solution in sequence to obtain the crude product of 5-methoxytryptamine.

18. The method for preparing 5-methoxytryptamine according to claim 17, characterized in that: The solvent used for the dilution is water.

19. The method for preparing 5-methoxytryptamine according to claim 18, characterized in that: The amount of water added is 2-10 times that of the concentrated product.

20. The method for preparing 5-methoxytryptamine according to claim 17, characterized in that: The dilution is carried out during stirring, the stirring temperature is 20-30° C., and the stirring time is 20-40 min.

21. The method for preparing 5-methoxytryptamine according to claim 1, characterized in that: After step (2), step (3) is required: the crude 5-methoxytryptamine is dissolved in an aqueous solution of ethanol, and then decolorized, crystallized, centrifuged and dried in sequence to obtain a pure 5-methoxytryptamine.

22. The method for preparing 5-methoxytryptamine according to claim 21, characterized in that: In step (3), the mass percentage of the ethanol aqueous solution is 10-60%.

23. The method for preparing 5-methoxytryptamine according to claim 21, characterized in that: In step (3), the mass ratio of the crude 5-methoxytryptamine to the aqueous solution of ethanol is 1:(1-5).

24. The method for preparing 5-methoxytryptamine according to claim 21, characterized in that: In step (3), the dissolving temperature is 50-90°C.

25. The method for preparing 5-methoxytryptamine according to claim 24, characterized in that: In step (3), the dissolving temperature is 75-85°C.

26. The method for preparing 5-methoxytryptamine according to claim 21, characterized in that: In step (3), activated carbon is used for decolorization, and the mass ratio of the crude 5-methoxytryptamine to the activated carbon is 1:(0.01-0.1).

27. The method for preparing 5-methoxytryptamine according to claim 21, characterized in that: In step (3), the decolorization temperature is 75-85°C and the decolorization time is 20-40 minutes.

28. The method for preparing 5-methoxytryptamine according to claim 21, characterized in that: In step (3), the crystallization temperature is below 10°C and the crystallization time is 0.5-2h.

29. The method for preparing 5-methoxytryptamine according to claim 21, characterized in that: In step (3), the centrifugal rotation speed is 3000-8000 rpm.

30. The method for preparing 5-methoxytryptamine according to claim 1, characterized in that: The preparation method of the 5-methoxytryptamine comprises the following steps: (1) adding 4-chlorobutyraldehyde dimethyl acetal to a mixed solution of 4-methoxyphenylhydrazine hydrochloride, ethanol and hydrochloric acid, stirring and reacting at 70-80° C. for 8-16 hours, cooling and concentrating after the reaction to obtain 3-(2-haloethyl)-5-methoxy-1H-indole; (2) adding 3-(2-haloethyl)-5-methoxy-1H-indole to a mixture of ammonia water and ethanol, stirring and reacting at 80-90° C. for 8-16 hours, and after the reaction is completed, cooling, concentrating, diluting and filtering are performed in sequence to obtain a crude product of 5-methoxytryptamine; (3) The crude product of 5-methoxytryptamine is added to an aqueous solution of ethanol, and then decolorized with activated carbon, crystallized, centrifuged and dried to obtain a pure product of 5-methoxytryptamine.